Antibody Response to SARS-CoV-2 mRNA Vaccine Poor in Transplant Recipients
Anti-S1 or anti-receptor-binding domain antibody detectable in 17 percent of solid organ transplant recipients after first dose
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.